What is Journey Medical Corporation's R&D?

Journey Medical Corporation (DERM) reported R&D of $154K in Q4 2025.

How has Journey Medical Corporation's R&D changed year-over-year?

Journey Medical Corporation's R&D decreased by 29.4% year-over-year, from $218K to $154K.

What is the long-term trend for Journey Medical Corporation's R&D?

Over 4 years (2021 to 2025), Journey Medical Corporation's R&D has grown at a -35.3% compound annual growth rate (CAGR), from $2.74M to $480K.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Journey Medical Corporation DERM R&D

R&D at other companies

Bausch Health CompaniesBHC

$163M+14.0%

Cumberland PharmaceuticalsCPIX

$1.46M+12.6%

PTH

Pelthos Therapeutics Inc.PTHS

$186K-4.1%

Arcutis Biotherapeutics, Inc.ARQT

$30.63M+74.6%

HRO

HarrowHROW

$5.9M+94.8%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

Other financials

Income statement

See full

Revenue$16.0M+21.5%

Gross profit$9.7M+16.7%

Operating income-$1.5M+55.1%

Net income-$2.2M+45.2%

EPS (diluted)-$0.08+55.6%

Balance sheet

See full

Cash & equivalents$27.2M+29.2%

Total debt$25.5M+1.2%

Total equity$30.8M+43.1%

Total assets$91.5M+7.7%

Cash flow

See full

Operating cash flow$2.9M+203%

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation

See full

Market cap$194.94M+20.9%

Enterprise value$193.19M+16.2%

P/S3×+0.2×

Profitability

See full

Gross margin65.4%-1.0pp

Operating margin-9.8%—

Net margin-14.8%—

FCF margin-43%—

Returns & leverage

See full

Return on equity-36.6%—

Debt / equity0.8×-0.3×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Journey Medical Corporation’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Journey Medical Corporation's R&D?: Journey Medical Corporation (DERM) reported R&D of $154K in Q4 2025.
How has Journey Medical Corporation's R&D changed year-over-year?: Journey Medical Corporation's R&D decreased by 29.4% year-over-year, from $218K to $154K.
What is the long-term trend for Journey Medical Corporation's R&D?: Over 4 years (2021 to 2025), Journey Medical Corporation's R&D has grown at a -35.3% compound annual growth rate (CAGR), from $2.74M to $480K.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.